Page last updated: 2024-08-25

ethyl 2-cyanoacrylate and Age-Related Osteoporosis

ethyl 2-cyanoacrylate has been researched along with Age-Related Osteoporosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asakura, H; Kato, M; Mizutani, T; Morishita, E; Myou, S; Nakao, S; Ontachi, Y; Saito, M; Yamazaki, M1

Trials

1 trial(s) available for ethyl 2-cyanoacrylate and Age-Related Osteoporosis

ArticleYear
Vitamin K administration to elderly patients with osteoporosis induces no hemostatic activation, even in those with suspected vitamin K deficiency.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2001, Volume: 12, Issue:12

    Topics: Aged; Aged, 80 and over; Blood Coagulation Factors; Cyanoacrylates; Female; Hemostasis; Hemostatics; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Vitamin K 1; Vitamin K 2; Vitamin K Deficiency

2001